Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Photodynamic Molecular Beacons as a Whole Joint Treatment of Osteoarthritis

FY 2017-18

Summary
Four million Canadians suffer from osteoarthritis (OA) and its associated debilitating joint pain and drastically decreased quality of life. Currently, there are no curative treatments that address the newfound knowledge that OA is a whole joint disease that includes degeneration of joint cartilage, joint inflammation, and bone damage. Effective treatments must be developed that extend beyond the management of symptoms or invasive joint surgery to address all of these disease complexities.Therefore, I am developing an OA-specific delivery platform for photodynamic therapy (PDT), called photodynamic molecular beacons, a first-of-its-kind, whole joint OA treatment. As a promising strategy for OA, PDT is a local light-based therapy that has earned clinical approval for the treatment of macular degeneration of the eye and various types of cancer. PDT can maximize the delivery of therapeutic treatment to the damaged osteoarthritic joint tissue while minimizing collateral damage to healthy tissues, like muscles and ligaments. Delivery via molecular beacons will allow for selective activation of PDT by the enzyme responsible for cartilage breakdown.PDT may induce beneficial effects in various joint tissues damaged in OA, addressing the disease from a whole joint approach. This activatable smart PDT offers a potentially-curative treatment for OA that will enhance the quality of life for millions of Canadians.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
386618
Name
Walsh Connor D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Photodynamic Molecular Beacons as a Whole Joint Treatment of Osteoarthritis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cartilage; Matrix Metalloproteinase 13; Molecular Beacon; Osteoarthritis; Photodynamic Therapy; Porphyrin
Abstract
Four million Canadians suffer from osteoarthritis (OA) and its associated debilitating joint pain and drastically decreased quality of life. Currently, there are no curative treatments that address the newfound knowledge that OA is a whole joint disease that includes degeneration of joint cartilage, joint inflammation, and bone damage. Effective treatments must be developed that extend beyond the management of symptoms or invasive joint surgery to address all of these disease complexities.Therefore, I am developing an OA-specific delivery platform for photodynamic therapy (PDT), called photodynamic molecular beacons, a first-of-its-kind, whole joint OA treatment. As a promising strategy for OA, PDT is a local light-based therapy that has earned clinical approval for the treatment of macular degeneration of the eye and various types of cancer. PDT can maximize the delivery of therapeutic treatment to the damaged osteoarthritic joint tissue while minimizing collateral damage to healthy tissues, like muscles and ligaments. Delivery via molecular beacons will allow for selective activation of PDT by the enzyme responsible for cartilage breakdown.PDT may induce beneficial effects in various joint tissues damaged in OA, addressing the disease from a whole joint approach. This activatable smart PDT offers a potentially-curative treatment for OA that will enhance the quality of life for millions of Canadians.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Walsh, Connor D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~